€ million
|
Note |
2009 |
2008 |
|
|
|
|
| Continuing operations |
|
|
|
|
|
|
|
| Sales |
3 |
2 611 |
5 474 |
| Cost of sales |
8 |
-2 764 |
-5 276 |
|
|
|
|
Gross margin
|
|
-153 |
199 |
| |
|
|
|
| Other operating income |
6 |
28 |
57 |
| Selling and marketing expenses |
8 |
-135 |
-122 |
| Administrative expenses |
8 |
-126 |
-134 |
| Research and development expenses |
8 |
-19 |
-20 |
| Other operating expenses |
7 |
-32 |
-42 |
|
|
|
|
| Operating profit |
|
-438 |
-63 |
|
|
|
|
| Share of results in associated companies |
15 |
-12 |
-2 |
| Financial income and expenses |
10 |
|
|
| Interest income |
|
17 |
20 |
| Interest expenses |
|
-38 |
-74 |
| Market price gains and losses |
|
-2 |
-2 |
| Other financial income |
|
5 |
11 |
| Other financial expenses |
|
-6 |
-24 |
| Total financial income and expenses |
|
-25 |
-69 |
|
|
|
|
| Profit before taxes |
|
-474 |
-134 |
| |
|
|
|
| Income taxes |
11 |
142 |
24 |
|
|
|
|
| Net profit for the financial year from continuing operations |
|
-332 |
-110 |
|
|
|
|
| Net profit for the financial year from discontinued operations |
4 |
-4 |
-79 |
|
|
|
|
| Net profit for the financial year |
|
-336 |
-189 |
|
|
|
|
| Attributable to |
|
|
|
| Equity holders of the Company |
|
-336 |
-189 |
| Minority interest |
|
-0 |
-0 |
|
|
|
|
| Earnings per share for result attributable to the equity holders of the Company |
|
|
|
| Earnings per share, € |
12 |
-1.86 |
-1.05 |
| Diluted earnings per share, € |
|
-1.86 |
-1.04 |
|
|
|
|
| Earnings per share from continuing operations attributable to the equity holders of the Company |
|
|
|
| Earnings per share, € |
|
-1.83 |
-0.61 |
| Diluted earnings per share, € |
|
-1.83 |
-0.61 |
|
|
|
|
| Earnings per share from discontinued operations attributable to the equity holders of the Company |
|
|
|
| Earnings per share, € |
|
-0.02 |
-0.44 |
| Diluted earnings per share, € |
|
-0.02 |
-0.43 |
